The Health & Nutrition Business Unit of Evonik Industries, Essen (Germany), has now published the latest edition of its customer magazine AMINONews® for the compound feed and livestock production industries.
In that issue our aqua specialist Dr. Andreas Lemme adresses the topic “Availability and effectiveness of free amino acids in aquaculture" for different fish species and shrimps.
The other two articles are:
- “Expect the best - the new AMINODat® 4.0”, by Dr Mark Redshaw
- “Optimum dietary tryptophan to lysine ratio for gestating and lactating sows”, by Dr John Htoo
Featured as “Research Highlights”, the magazine also reports on current developments and latest scientific publications on amino acids for animal nutrition.
Evonik is the only company in the world that produces and markets all four essential amino acids used in advanced animal nutrition: MetAmino® (DL-Methionine), Biolys® (L-Lysine), ThreAmino® (L-Threonine) and TrypAmino® (L-Tryptophan). The company markets innovative products and services in more than one hundred countries and thus makes a valuable contribution to the cost-efficiency of its customers and to healthy and environment-friendly animal nutrition.
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals. Its activities focus on the key megatrends health and nutrition, resource efficiency and globalization. In 2010 about 80 percent of the Group’s chemicals sales came from activities where it ranks among the market leaders. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2010 more than 34,000 employees generated sales of around €13.3 billion and an operating profit (EBITDA) of about €2.4 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.